Gilead Sciences (GILD) Long-Term Investments (2009 - 2026)

Gilead Sciences (GILD) has 17 years of Long-Term Investments data on file, last reported at $983.0 million in Q1 2026.

• For the quarter ending Q1 2026, Long-Term Investments changed N/A year-over-year to $983.0 million; the trailing twelve-month figure through Mar 2026 stood at $983.0 million (changed N/A YoY), and the FY2025 full-year result was $3.0 billion, changed N/A from the prior year.
• Long-Term Investments for Q1 2026 stood at $983.0 million, down from $3.0 billion in the prior quarter.
• Across five years, Long-Term Investments topped out at $3.0 billion in Q4 2025 and bottomed at $983.0 million in Q1 2026.
• The 4-year median for Long-Term Investments is $1.3 billion (2023), against an average of $1.5 billion.
• The widest annual swing landed in 2022, when Long-Term Investments jumped 146.46%; it then declined 9.83% in 2023.
• A 4-year view of Long-Term Investments shows it stood at $1.2 billion in 2022, then dropped by 6.59% to $1.2 billion in 2023, then surged by 155.72% to $3.0 billion in 2025, then plunged by 66.95% to $983.0 million in 2026.
• The last three Long-Term Investments figures came in at $983.0 million (Q1 2026), $3.0 billion (Q4 2025), and $2.0 billion (Q3 2025), per Business Quant data.

Peer Comparison